Quarterly report pursuant to Section 13 or 15(d)

SEGMENT REPORTING (Tables)

v3.22.1
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table is a comparative summary of the Company’s net sales and segment profit by reportable segment for the periods presented:
Three Months Ended March 31,
  2022 2021
Segment Net Sales:
Cannabinoid $ 1,994  $ 677 
Non-Cannabinoid 3,230  2,800 
Total net sales 5,224  3,477 
 
Segment Profit (Loss):
Cannabinoid (7,688) (2,864)
Non-Cannabinoid 348  612 
Total segment loss $ (7,340) $ (2,252)
 
Reconciliation:
Total segment loss (7,340) (2,252)
Unallocated corporate expenses (3,536) (3,387)
Non-cash share-based compensation (500) (1,550)
Depreciation and amortization (517) (579)
Loss from continuing operations before income taxes $ (11,893) $ (7,768)
 
Loss on debt extinguishment, net 2,263  — 
(Gain) loss on remeasurement of warrant liability (490) 4,851 
Foreign exchange loss 345  759 
Interest and amortization of debt issuance cost 2,118  978 
Other income, net (53) (602)
Loss before loss from equity investment $ (16,076) $ (13,754)
Disaggregation of Revenue
The following table disaggregates the Company’s revenue by channel for the periods presented:

Three Months Ended March 31,
2022 2021
Mass retail $ 2,997  $ 1,888 
Distributors 1,658  1,232 
Specialty, health and other retail 392  225 
E-commerce 177  132 
Total $ 5,224  $ 3,477 

The following table represents the Company's revenues attributed to countries based on location of customer:
Three Months Ended March 31,
2022 2021
United States $ 3,233  $ 2,800 
Israel $ 638  $ — 
Australia 368  282 
Brazil 643  142 
Other 342  253 
 Total $ 5,224  $ 3,477 
Schedule of Revenue by Major Customers by Reporting Segments
During the three months ended March 31, 2022 and 2021, the majority of the Company's net sales for the non-cannabinoid segment were in the U.S.

Percentage of Revenues Percentage of Accounts Receivable
Three Months Ended March 31, 2022 March 31, December 31,
2022 2021 2022 2021
Customer A * * 28% *
Customer B (a)
11% 19% 14% 25%
Customer C (b)
12% * 32% 18%
Customer D (a)
* 10% * *
Customer E (b)
12% * * *
* denotes less than 10%

(a) net sales attributed are reflected in the non-cannabinoid segments
(b) net sales attributed are reflected in the cannabinoid segments
Long-lived Assets by Geographic Areas
March 31,
2022
December 31,
2021
Long-lived assets
   
Colombia $ 17,586  $ 18,950 
Portugal 12,245  11,733 
Other(a)
225  249 
Total $ 30,056  $ 30,932 
(a)“Other” includes long-lived assets primarily in the U.S.